<!DOCTYPE html>
<html lang="en">
<head>
    <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-1324510872881128" crossorigin="anonymous"></script>
    <!-- Google tag (gtag.js) -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-V5VD1VSYT5"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      gtag('config', 'G-V5VD1VSYT5');
    </script>
    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-KJR6Q87B');</script>
    <!-- End Google Tag Manager -->

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <title>Neurology & Psychiatry - Krok World</title>
    <link rel="stylesheet" href="index.css">
    
    <style>
        .article-content {
            background-color: var(--content-bg);
            padding: 30px;
            border-radius: 5px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            font-family: "Segoe UI", Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            margin-bottom: 50px;
        }

        .article-content h1 {
            color: var(--brand-color);
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 15px;
            margin-bottom: 10px;
            font-family: "Consolas", sans-serif;
        }

        .article-content h2 {
            color: var(--text-color);
            margin-top: 35px;
            margin-bottom: 15px;
            border-left: 4px solid var(--brand-color);
            padding-left: 10px;
            font-family: "Consolas", sans-serif;
        }

        .article-content h3 {
            color: var(--content-link-color);
            margin-top: 25px;
            font-weight: bold;
            font-family: "Consolas", sans-serif;
        }

        .article-content p {
            margin-bottom: 15px;
            text-align: justify;
        }

        .authors {
            font-style: italic;
            color: var(--text-color);
            opacity: 0.8;
            margin-bottom: 30px;
            display: block;
        }

        .key-points {
            background-color: var(--collapsible-bg);
            border: 1px solid var(--border-color);
            padding: 20px;
            border-radius: 5px;
            margin-bottom: 30px;
        }

        .key-points ul, .article-content ul {
            padding-left: 20px;
            list-style-type: disc;
        }
        
        .key-points li, .article-content li {
            margin-bottom: 10px;
        }

        .figure-box {
            background-color: var(--nav-bg-color);
            border: 1px solid var(--border-color);
            padding: 20px;
            border-radius: 5px;
            margin: 20px 0;
            font-size: 0.9em;
        }
        
        .process-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(180px, 1fr));
            gap: 10px;
            margin-top: 15px;
        }

        .process-item {
            background: var(--collapsible-bg);
            color: var(--text-color);
            padding: 10px;
            border: 1px solid var(--border-color);
            text-align: center;
            border-radius: 3px;
        }

        .citation {
            font-size: 0.85em;
            opacity: 0.7;
            font-style: italic;
        }

        strong { color: var(--brand-color); }

        .guideline-box {
            border: 1px dashed var(--brand-color);
            padding: 15px;
            margin: 20px 0;
            background-color: rgba(255, 255, 255, 0.02);
        }
    </style>
</head>

<body data-theme="dark">
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KJR6Q87B" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

    <nav class="navbar">
        <a href="index.html" class="brand notranslate">KrokWorld</a>
        <input type="checkbox" id="nav-toggle" class="nav-toggle">
        <label for="nav-toggle" class="nav-toggle-label"><span></span></label>
        <div class="nav-links">
            <a href="index.html">Home</a>
            <a href="Guide.html">Guide</a>
            <a href="Contact.html">Contact us</a>
            <div class="theme-switch-wrapper">
                <label class="theme-switch" for="checkbox">
                    <input type="checkbox" id="checkbox" />
                    <div class="slider round"></div>
                </label>
            </div>
        </div>
    </nav>

    <div class="main-content">
        <a href="main.html" style="color: var(--brand-color); text-decoration: none; margin-bottom: 20px; display: inline-block;">&larr; Back to Bases</a>

        <!-- ARTICLE 1: PARKINSON’S DISEASE -->
        <div class="article-content">
            <h1>Parkinson’s Disease</h1>
            <span class="authors">Therapeutics Core Knowledge</span>

            <div class="key-points">
                <h3>Key Points</h3>
                <ul>
                    <li>Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 1% of the population over 65.</li>
                    <li>Characterised by bradykinesia, resting tremor, rigidity and postural instability.</li>
                    <li>Non-motor features (psychiatric, cognitive, autonomic) contribute significantly to impaired quality of life.</li>
                    <li>Neuronal loss in the substantia nigra leads to dopamine deficiency in the striatum.</li>
                    <li>Levodopa remains the most potent oral treatment, though motor fluctuations (on–off) occur with long-term use.</li>
                    <li>Dopamine agonists are alternatives, but carry risks of impulse control disorders.</li>
                </ul>
            </div>

            <div class="figure-box">
                <span style="font-weight:bold; color:var(--brand-color);">Fig. 32.1 Summary of Pathophysiological Processes:</span>
                <div class="process-grid">
                    <div class="process-item">Ageing</div>
                    <div class="process-item">Genetic factors</div>
                    <div class="process-item">Oxidative stress</div>
                    <div class="process-item">Protein aggregation</div>
                    <div class="process-item">Mitochondrial dysfunction</div>
                    <div class="process-item">Inflammation</div>
                    <div class="process-item">Synaptic dysfunction</div>
                    <div class="process-item">Impaired trafficking</div>
                </div>
                <p style="text-align: center; margin-top: 15px; border-top: 1px solid var(--border-color); padding-top:10px;"><strong>Result: CELL DEATH</strong></p>
            </div>

            <h2>Environment & Genetics</h2>
            <p>Environmental factors like pesticide exposure, rural living, and well water drinking are associated with increased PD risk. Conversely, tobacco smoking and coffee drinking have been linked to a reduced risk <span class="citation">(Bellou et al., 2016)</span>. Genetics play a role in a minority of cases, with mutations in the <strong>α-synuclein</strong> and <strong>GBA</strong> genes being strong risk factors.</p>

            <h2>Pathophysiology</h2>
            <p>PD is defined by neuronal loss in the substantia nigra and the presence of <strong>Lewy bodies</strong> (eosinophilic inclusion bodies). The Braak hypothesis proposes that α-synuclein pathology may start in the lower brainstem (dorsal vagal nucleus) or olfactory bulb, explaining why sense of smell and bowel issues often precede motor symptoms.</p>

            <h2>Clinical Features</h2>
            <h3>Motor Features</h3>
            <p><strong>Bradykinesia</strong> (slowness of movement) is a prerequisite for diagnosis. Other cardinal signs are a pill-rolling <strong>resting tremor</strong>, <strong>cogwheel rigidity</strong>, and <strong>postural instability</strong>. Patients often show a stooped posture, reduced arm swing, and <strong>micrographia</strong> (small handwriting).</p>
            
            <h3>Non-motor Features</h3>
            <ul>
                <li><strong>Autonomic:</strong> Postural hypotension and chronic constipation.</li>
                <li><strong>Psychiatric:</strong> Depression (40% of patients), paranoia, and hallucinations (often drug-induced).</li>
                <li><strong>Cognitive:</strong> Dementia develops in up to 80% of patients long-term <span class="citation">(Hely et al., 2008)</span>.</li>
                <li><strong>Sleep:</strong> REM sleep behavioural disorder (acting out dreams).</li>
            </ul>

            <h2>Differential Diagnosis</h2>
            <p><strong>Essential Tremor (ET)</strong> is commonly confused with PD but lacks bradykinesia. Other "Parkinson-plus" syndromes include Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). <strong>Drug-induced Parkinsonism</strong> (caused by neuroleptics or antiemetics like prochlorperazine) is potentially reversible.</p>
        </div>

        <!-- ARTICLE 2: SCHIZOPHRENIA -->
        <div class="article-content">
            <h1>Schizophrenia</h1>
            <span class="authors">Caroline Parker</span>

            <div class="key-points">
                <h3>Key Points</h3>
                <ul>
                    <li>Lifetime prevalence is 1 in 100 people; up to 10% commit suicide.</li>
                    <li>Positive symptoms (hallucinations, delusions) usually respond to antipsychotics.</li>
                    <li>Negative symptoms (apathy, social withdrawal) are more resistant to medication.</li>
                    <li>Second-generation (atypical) antipsychotics generally avoid EPSE but cause weight gain and diabetes.</li>
                    <li><strong>Clozapine</strong> is the most effective drug but requires mandatory blood monitoring for neutropenia.</li>
                </ul>
            </div>

            <h2>Classification & Symptoms</h2>
            <p>Kraepelin initially called it ‘dementia praecox’. Bleuler later introduced ‘schizophrenia’ to describe the split between emotions and intellect. It is categorized by:</p>
            <ul>
                <li><strong>Positive Symptoms:</strong> Hallucinations (mostly auditory), delusions (thought insertion), and thought disorder.</li>
                <li><strong>Negative Symptoms:</strong> Apathy, social withdrawal, and lack of drive.</li>
            </ul>

            <h2>Causes & Models</h2>
            <p>The <strong>Dopamine Hypothesis</strong> suggests overactivity at D2 receptors causes psychosis. The <strong>Developmental Model</strong> points to structural brain abnormalities during fetal development. Environmental triggers include urban living, childhood trauma, and substance misuse.</p>

            <div class="figure-box">
                <span style="font-weight:bold; color:var(--brand-color);">Fig. 30.1 Classification of Antipsychotics:</span>
                <div class="process-grid">
                    <div class="process-item"><strong>First Gen (Typical):</strong> Haloperidol, Chlorpromazine</div>
                    <div class="process-item"><strong>Second Gen (Atypical):</strong> Olanzapine, Risperidone</div>
                    <div class="process-item"><strong>Partial Agonist:</strong> Aripiprazole</div>
                    <div class="process-item"><strong>Refractory Gold Standard:</strong> Clozapine</div>
                </div>
            </div>

            <h2>Side Effects</h2>
            <ul>
                <li><strong>EPSE:</strong> Parkinsonism, Akathisia (restlessness), and Acute Dystonia (sustained muscle contraction).</li>
                <li><strong>Tardive Dyskinesia:</strong> Rhythmic involuntary movements of the tongue/face; often irreversible.</li>
                <li><strong>Metabolic:</strong> Significant weight gain and diabetes risk, especially with Olanzapine and Clozapine.</li>
                <li><strong>NMS:</strong> Neuroleptic Malignant Syndrome – a serious emergency with fever, rigidity, and autonomic instability.</li>
            </ul>

            <h2>Clozapine & Refractory Illness</h2>
            <p>Clozapine is indicated after failing two other antipsychotics. It carries a risk of <strong>agranulocytosis</strong> (low white blood cells) and requires titration to avoid tachycardia and seizures. Augmentation with sulpiride or amisulpride is sometimes used if response is inadequate.</p>
        </div>

        <!-- ARTICLE 3: EPILEPSY -->
        <div class="article-content">
            <h1>Epilepsy</h1>
            <span class="authors">Gonçalo Cação and Josemir W. Sander</span>

            <div class="key-points">
                <h3>Key Points</h3>
                <ul>
                    <li>An epileptic seizure is a transient paroxysm of uncontrolled neuronal discharges.</li>
                    <li>Incidence is highest in the first two decades and in late life (due to stroke).</li>
                    <li>60–70% of people become seizure-free on treatment.</li>
                    <li><strong>SUDEP:</strong> Sudden unexpected death in epilepsy is a risk for those with frequent convulsions.</li>
                    <li>Diagnosis is primarily clinical, supported by EEG and MRI.</li>
                </ul>
            </div>

            <h2>Pathophysiology</h2>
            <p>The hallmark is rhythmic, repetitive hyper-synchronous discharge of neurones. These discharges can be localized (focal) or involve the whole cortex (generalised). Neurones switch from normal low-frequency patterns to high-frequency bursts.</p>

            <h2>Clinical Manifestations</h2>
            <h3>Generalised Seizures</h3>
            <ul>
                <li><strong>Tonic-clonic:</strong> Stiffening (tonic) followed by jerking (clonic). Often followed by confusion/sleep.</li>
                <li><strong>Absence:</strong> Brief (seconds) behavioural arrest/staring; common in children.</li>
                <li><strong>Myoclonic:</strong> Sudden, brief, shock-like jerks, usually in the morning.</li>
                <li><strong>Atonic:</strong> Sudden loss of muscle tone causing a "drop attack."</li>
            </ul>

            <h3>Focal Seizures</h3>
            <p>Divided into <strong>Focal Aware</strong> and <strong>Focal with Impaired Awareness</strong>. Symptoms depend on the brain area affected (e.g., lip smacking, déjà vu, or localized jerking). These may evolve into bilateral tonic-clonic seizures.</p>

            <div class="guideline-box">
                <h3>NICE Management Summary (2014)</h3>
                <p><strong>Emergency Treatment:</strong> <strong>Buccal midazolam</strong> is first-line for prolonged seizures in the community. Rectal diazepam is an alternative. Intravenous lorazepam is used in hospitals.</p>
                <p><strong>Diagnosis:</strong> Should be made urgently by a specialist. Diagnosis is clinical; EEG classifies the syndrome but does not "prove" epilepsy if the history is weak.</p>
                <p><strong>Women:</strong> Must receive counseling on contraception (interaction with AEDs) and the risks of sodium valproate in pregnancy.</p>
            </div>

            <h2>Diagnosis & Treatment</h2>
            <p><strong>MRI</strong> is essential for identifying structural causes like tumours or cortical dysplasia. <strong>EEG</strong> helps classify the seizure type. Treatment aims for seizure freedom using a single drug (monotherapy) to minimize side effects. If two drugs fail, the patient is considered "refractory" and should be referred for surgery evaluation.</p>
        </div>
    </div>

    <script>
        // Navbar Scroll Script
        const navbar = document.querySelector('.navbar');
        let lastScrollY = window.scrollY;
        window.addEventListener('scroll', () => {
            if (window.scrollY > lastScrollY && window.scrollY > navbar.clientHeight) {
                navbar.classList.add('navbar-scrolled');
            } else {
                navbar.classList.remove('navbar-scrolled');
            }
            lastScrollY = window.scrollY;
        });

        // Theme Switcher Script
        const themeSwitch = document.querySelector('#checkbox');
        const currentTheme = localStorage.getItem('theme');
        if (!currentTheme) {
            localStorage.setItem('theme', 'dark');
            document.documentElement.setAttribute('data-theme', 'dark');
        } else {
            document.documentElement.setAttribute('data-theme', currentTheme);
            if (currentTheme === 'light') { themeSwitch.checked = true; }
        }
        themeSwitch.addEventListener('change', (e) => {
            const theme = e.target.checked ? 'light' : 'dark';
            document.documentElement.setAttribute('data-theme', theme);
            localStorage.setItem('theme', theme);
        }, false);
    </script>

    <div class="footer">
        <a href="insomnia.html" style="color: #cacaca;">Next : Insomnia</a>
    </div>
    <div class="footer">
        <a href="privacy.html" style="color: red;">Privacy Policy</a>
    </div>
</body>
</html>
